Synairgen Statistics
Total Valuation
Synairgen has a market cap or net worth of 330,798. The enterprise value is -10.53 million.
| Market Cap | 330,798 |
| Enterprise Value | -10.53M |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Synairgen has 1.10 billion shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 1.10B |
| Shares Outstanding | 1.10B |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 10.55% |
| Float | 142.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.03 |
| P/TBV Ratio | 0.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.20 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.26 |
Financial Position
The company has a current ratio of 9.76
| Current Ratio | 9.76 |
| Quick Ratio | 9.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.24% and return on invested capital (ROIC) is -42.53%.
| Return on Equity (ROE) | -54.24% |
| Return on Assets (ROA) | -36.99% |
| Return on Invested Capital (ROIC) | -42.53% |
| Return on Capital Employed (ROCE) | -90.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -243,034 |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.48% in the last 52 weeks. The beta is 0.71, so Synairgen's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -98.48% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 12.40 |
| Average Volume (20 Days) | 656 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.98M |
| Pretax Income | -10.24M |
| Net Income | -8.75M |
| EBITDA | -10.92M |
| EBIT | -10.98M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 10.86 million in cash and n/a in debt, giving a net cash position of 10.86 million or 0.01 per share.
| Cash & Cash Equivalents | 10.86M |
| Total Debt | n/a |
| Net Cash | 10.86M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 12.08M |
| Book Value Per Share | 0.06 |
| Working Capital | 11.94M |
Cash Flow
In the last 12 months, operating cash flow was -8.36 million and capital expenditures -15,165, giving a free cash flow of -8.37 million.
| Operating Cash Flow | -8.36M |
| Capital Expenditures | -15,165 |
| Free Cash Flow | -8.37M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Synairgen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | -2,644.88% |
| FCF Yield | -2,530.65% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |